Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey
| dc.contributor.author | Unal, Caglar | |
| dc.contributor.author | Ozmen, Tolga | |
| dc.contributor.author | Ordu, Cetin | |
| dc.contributor.author | Pilanci, Kezban Nur | |
| dc.contributor.author | Ilgun, Ahmet Serkan | |
| dc.contributor.author | Gokmen, Erhan | |
| dc.contributor.author | Almuradova, Elvina | |
| dc.contributor.author | Ozdogan, Mustafa | |
| dc.contributor.author | Guler, Niluefer | |
| dc.contributor.author | Uras, Cihan | |
| dc.contributor.author | Kara, Halil | |
| dc.contributor.author | Demircan, Orhan | |
| dc.contributor.author | Isik, Selver | |
| dc.contributor.author | Alco, Gul | |
| dc.contributor.author | Saip, Pinar | |
| dc.contributor.author | Aydin, Esra | |
| dc.contributor.author | Duymaz, Tomris | |
| dc.contributor.author | Celebi, Filiz | |
| dc.contributor.author | Yararbas, Kanay | |
| dc.contributor.author | Soybir, Gursel | |
| dc.contributor.author | Ozmen, Vahit | |
| dc.date.accessioned | 2025-10-16T15:15:03Z | |
| dc.date.issued | 2023 | |
| dc.identifier.doi | 10.3389/fonc.2023.1151733 | |
| dc.identifier.other | WOS:001027956800001 | |
| dc.identifier.uri | https://openaccess.acibadem.edu.tr/handle/11443/6356 | |
| dc.publisher | FRONTIERS MEDIA SA | |
| dc.source | FRONTIERS IN ONCOLOGY | |
| dc.subject | clinicopathologic characteristics | |
| dc.subject | early\\-stage breast cancer | |
| dc.subject | lymph node\\-negative | |
| dc.subject | Oncotype DX \\(R\\) | |
| dc.subject | recurrence score | |
| dc.subject | 21 genes | |
| dc.title | Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey | |
| dc.type | Article |
